- Previous Close
1.2300 - Open
1.1750 - Bid 1.1950 x --
- Ask 1.5300 x --
- Day's Range
1.1600 - 1.1950 - 52 Week Range
0.8200 - 4.8047 - Volume
15 - Avg. Volume
0 - Market Cap (intraday)
2.807M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, pulsating left ventricle assist; PulsePump, pulsating flow for heart and lung machines; and Sternal Prosthesis, to fix the sternum after open-chest surgery. The company was incorporated in 2007 and is based in Västerås, Sweden.
realheart.seRecent News: 7820.F
View MorePerformance Overview: 7820.F
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7820.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7820.F
View MoreValuation Measures
Market Cap
2.81M
Enterprise Value
1.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.42
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.31%
Return on Equity (ttm)
-45.99%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-34.35M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
23.72M
Total Debt/Equity (mrq)
9.43%
Levered Free Cash Flow (ttm)
-30.65M